title: Effect of exercise on cardiac tissue oxidative and inflammatory mediators in chronic kidney disease.
abstract: BACKGROUND
  Chronic renal failure (CRF) results in diminished physical activity and increased risk of cardiovascular disease (CVD). CVD risk factors are raised by sedentary life style and ameliorated by physical fitness in the general population. Accordingly, exercise improves hypertension, endothelial dysfunction, insulin resistance, dyslipidemia, inflammation and oxidative stress in high-risk populations. This study was designed to explore the effect of exercise on oxidative and inflammatory mediators in the left ventricle (LV) of CRF rats.
  
  
  RESULTS
  One week after 5/6 nephrectomy female rats were housed in either regular cages or cages equipped with running wheels for 4 weeks. Sham-operated rats housed in regular cages served as controls. Sedentary CRF rats exhibited azotemia, hypertension, anemia, oxidative stress, activation of NF-kappaB and upregulations of reactive oxygen species-generating enzyme, NAD(P)H oxidase, MCP-1, cyclooxygenase-2 (COX-2), and PAI-1 in LV. The CRF rats assigned to the exercise group ran 6.8 +/- 0.7 km/day and 72 +/- 8 min/day. Voluntary exercise reversed NF-kappaB activation and lowered NAD(P)H oxidase, PAI-1, MCP-1 and COX-2 abundance, increased LV mass by raising myofibrillar proteins and ameliorated anemia without affecting renal function or arterial pressure.
  
  
  CONCLUSIONS
  CRF resulted in upregulation of prooxidant/proinflammatory pathways in LV. These changes were ameliorated by exercise, which indicates the potential cardiovascular benefit of exercise in renal insufficiency.
authors.affiliation: Division of Nephrology and Hypertension, University of California Irvine, Irvine, CA 92868, USA.
authors.forename: Y
authors.initials: Y
authors.lastname: Bai
authors.forename: W
authors.initials: W
authors.lastname: Sigala
authors.forename: G R
authors.initials: GR
authors.lastname: Adams
authors.forename: N D
authors.initials: ND
authors.lastname: Vaziri
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000378:metabolism; D015415:Biomarkers / Q000378:metabolism; D018932:Chemokine CCL2 / Q000378:metabolism; D051546:Cyclooxygenase 2 / Q000378:metabolism; D005260:Female; D006352:Heart Ventricles / Q000473:pathology; D018836:Inflammation Mediators / Q000378:metabolism*; D007676:Kidney Failure, Chronic / Q000378:metabolism* / Q000473:pathology; D009205:Myocarditis / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism*; D019255:NADPH Oxidases / Q000378:metabolism; D016328:NF-kappa B / Q000378:metabolism; D009929:Organ Size; D018384:Oxidative Stress; D010805:Physical Conditioning, Animal / Q000502:physiology*; D017395:Plasminogen Activator Inhibitor 1 / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D000975:Antioxidants; D015415:Biomarkers; C491766:Ccl2 protein, rat; D018932:Chemokine CCL2; D018836:Inflammation Mediators; D016328:NF-kappa B; D017395:Plasminogen Activator Inhibitor 1; D051546:Cyclooxygenase 2; C489691:Ptgs2 protein, rat; D019255:NADPH Oxidases
references.citation: Semin Dial. 2002 Sep-Oct;15(5):329-37
references.pmid: 12358637
references.citation: Pharmacol Ther. 2004 Apr;102(1):87-96
references.pmid: 15056500
references.citation: N Engl J Med. 2004 Sep 23;351(13):1296-305
references.pmid: 15385656
references.citation: Hypertension. 1997 Dec;30(6):1487-92
references.pmid: 9403571
references.citation: Nat Clin Pract Nephrol. 2006 Apr;2(4):209-20
references.pmid: 16932427
references.citation: Circ Res. 2002 Jun 14;90(11):1205-13
references.pmid: 12065324
references.citation: Arterioscler Thromb Vasc Biol. 2000 Aug;20(8):1903-11
references.pmid: 10938010
references.citation: Semin Nephrol. 2004 Sep;24(5):469-73
references.pmid: 15490413
references.citation: Kidney Int. 2002 Nov;62(5):1524-38
references.pmid: 12371953
references.citation: J Am Coll Cardiol. 2002 Nov 20;40(10):1856-63
references.pmid: 12446071
references.citation: Adv Exp Med Biol. 1997;432:63-9
references.pmid: 9433512
references.citation: Cardiovasc Res. 2005 Aug 1;67(2):187-97
references.pmid: 15935334
references.citation: Clin Nephrol. 2002 Jul;58 Suppl 1:S62-72
references.pmid: 12227729
references.citation: J Am Coll Cardiol. 2001 Sep;38(3):860-6
references.pmid: 11527646
references.citation: Curr Opin Nephrol Hypertens. 2004 Jan;13(1):93-9
references.pmid: 15090865
references.citation: CMAJ. 2006 Mar 14;174(6):801-9
references.pmid: 16534088
references.citation: J Hypertens. 2004 Mar;22(3):451-4
references.pmid: 15076146
references.citation: Med Sci Sports Exerc. 2005 Apr;37(4):557-62
references.pmid: 15809552
references.citation: Circ Res. 2000 Mar 17;86(5):494-501
references.pmid: 10720409
references.citation: Kidney Int. 2003 Jan;63(1):179-85
references.pmid: 12472781
references.citation: Kidney Int. 1998 Jun;53(6):1748-54
references.pmid: 9607208
references.citation: FASEB J. 2000 Sep;14(12):1685-96
references.pmid: 10973917
references.citation: Nat Clin Pract Nephrol. 2006 Oct;2(10):582-93
references.pmid: 17003837
references.citation: Kidney Blood Press Res. 2004;27(1):43-62
references.pmid: 14691350
references.citation: Am J Kidney Dis. 2001 Oct;38(4 Suppl 1):S74-9
references.pmid: 11576927
references.citation: Circulation. 2005 Feb 8;111(5):555-62
references.pmid: 15699275
references.citation: Hypertension. 2003 Dec;42(6):1075-81
references.pmid: 14581295
references.citation: Semin Nephrol. 2004 Sep;24(5):431-6
references.pmid: 15490405
references.citation: J Pharmacol Exp Ther. 2007 Oct;323(1):85-93
references.pmid: 17636006
references.citation: Circulation. 2002 Nov 12;106(20):2530-2
references.pmid: 12427646
references.citation: Am J Physiol Renal Physiol. 2002 Nov;283(5):F985-94
references.pmid: 12372774
references.citation: Am J Physiol Regul Integr Comp Physiol. 2003 Aug;285(2):R277-97
references.pmid: 12855411
references.citation: Kidney Int. 2003 Dec;64(6):2172-81
references.pmid: 14633140
references.citation: J Appl Physiol (1985). 2006 May;100(5):1657-65
references.pmid: 16357066
references.citation: Circ Res. 2001 May 11;88(9):947-53
references.pmid: 11349005
references.citation: Med Sci Sports Exerc. 2001 Mar;33(3):368-70
references.pmid: 11252060
references.citation: Circ Res. 2002 Sep 6;91(5):406-13
references.pmid: 12215489
references.citation: Clin Sci (Lond). 2006 Apr;110(4):409-25
references.pmid: 16526946
references.citation: Am J Physiol Renal Physiol. 2004 May;286(5):F945-54
references.pmid: 15075190
references.citation: Am J Physiol. 1998 Apr;274(4):F642-9
references.pmid: 9575886
references.citation: Am J Cardiol. 1972 Nov;30(7):775-80
references.pmid: 5084775
references.citation: Ann Intern Med. 2002 Apr 2;136(7):493-503
references.pmid: 11926784
references.citation: Am J Physiol Renal Physiol. 2006 Feb;290(2):F262-72
references.pmid: 16403839
references.citation: Curr Hypertens Rep. 2005 Feb;7(1):61-7
references.pmid: 15683588
references.citation: J Nutr. 2005 Aug;135(8):1829-35
references.pmid: 16046704
references.citation: Sports Med. 1999 Oct;28(4):237-44
references.pmid: 10565550
references.citation: Circulation. 2005 Apr 19;111(15):1962-9
references.pmid: 15837950
references.citation: Am J Physiol Heart Circ Physiol. 2000 Oct;279(4):H1999-2005
references.pmid: 11009490
references.citation: J Am Soc Nephrol. 2004 May;15(5):1307-15
references.pmid: 15100371
references.citation: Eur J Immunol. 1995 Jan;25(1):159-65
references.pmid: 7843227